Don't Miss

New Report Now Available
How do payer and industry experts predict PAPs will need to change in the future in order to continue delivering competitive advantage? Based on in-depth interviews with national payers and pharma executives, Patient Assistance Programs: Payer and Pharma Perspectives surveys the current PAP environment to provide a qualitative analysis of the trends, issues and challenges that will determine the future for PAPs. Learn more.

Amgen ends studies of rilotumumab in advanced gastric cancer after patient deaths